₹2300
(Inclusive of all Taxes)
Get Free delivery (₹99) with



Composition :
Manufacturer/Marketer :
Consume Type :
Return Policy :
About Cetrohope 0.25 mg PFS Injection 0.5 ml
Cetrohope 0.25 mg PFS Injection 0.5 ml belongs to the class of drugs called hormones used to treat female infertility in women. Infertility is unable to become pregnant after trying for a year. Female infertility may be caused due to different factors affecting ovulation (release of an egg from the ovary), fertilization (fusion of sperm and egg), and implantation (fertilized egg attaches to uterus lining).
If eggs are released too early during fertility treatment, they may not be suitable for fertilization. Cetrohope 0.25 mg PFS Injection 0.5 ml contains Cetrorelix, an anti-gonadotropin-releasing hormone that works by blocking a natural hormone in the body. Thereby, it inhibits premature ovulation (the release of eggs from the ovary too early).
Take Cetrohope 0.25 mg PFS Injection 0.5 ml as prescribed by your doctor. You are advised to take Cetrohope 0.25 mg PFS Injection 0.5 ml for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience itching, redness, or swelling at the site of injection, headache, or nausea. Most of these side effects of Cetrohope 0.25 mg PFS Injection 0.5 ml do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Cetrohope 0.25 mg PFS Injection 0.5 ml or any other medicines, please tell your doctor. Avoid taking Cetrohope 0.25 mg PFS Injection 0.5 ml if you are pregnant or breastfeeding, and consult a doctor before taking Cetrohope 0.25 mg PFS Injection 0.5 ml. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of the ovarian hyper-stimulation syndrome (OHSS).
Uses of Cetrohope 0.25 mg PFS Injection 0.5 ml
Cetrohope 0.25 mg PFS Injection 0.5 ml used in the treatment of Female infertility. The detailed uses of Cetrohope 0.25 mg PFS Injection 0.5 ml are as follows:

Have a query?
Directions for Use
Key Benefits
Cetrohope 0.25 mg PFS Injection 0.5 ml contains Cetrorelix, a hormone that blocks a natural hormone in the body. Thereby, it inhibits premature ovulation (release of eggs from the ovary too early). If eggs are released too early during fertility treatment, they may not be suitable for fertilization.
How Cetrohope 0.25 mg PFS Injection 0.5 ml Works
Storage
What if I have taken an overdose of Cetrohope 0.25 mg PFS Injection 0.5 ml
Drug Warnings
If you are allergic to Cetrohope 0.25 mg PFS Injection 0.5 ml or any other medicines, please tell your doctor. If you have any kidney or liver problems, inform your doctor before taking Cetrohope 0.25 mg PFS Injection 0.5 ml. Avoid taking Cetrohope 0.25 mg PFS Injection 0.5 ml if you are pregnant or breastfeeding, and consult a doctor before taking Cetrohope 0.25 mg PFS Injection 0.5 ml. You are recommended to remove Cetrohope 0.25 mg PFS Injection 0.5 ml from the refrigerator 30 minutes before using it. Wash your hands and inject Cetrohope 0.25 mg PFS Injection 0.5 ml under the skin of the belly as instructed by your doctor. If you experience lower stomach pain with nausea or vomiting, please consult a doctor immediately as these might be signs of ovarian hyper-stimulation syndrome (OHSS).
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
RXEris Life Sciences Ltd
₹1607.13
(₹321.43/ 1ml)
RX₹650
(₹650.0 per unit)
RX₹1010
(₹1010.0/ 1ml)
Alcohol
Caution
The interaction of Cetrohope 0.25 mg PFS Injection 0.5 ml with alcohol is unknown. Please consult a doctor before consuming alcohol while using Cetrohope 0.25 mg PFS Injection 0.5 ml.
Pregnancy
Unsafe
Cetrohope 0.25 mg PFS Injection 0.5 ml is a category X pregnancy drug and is not recommended for use during pregnancy as it may cause miscarriage, stillbirth, or birth defects. However, please consult a doctor if you are pregnant.
Breast Feeding
Unsafe
Cetrohope 0.25 mg PFS Injection 0.5 ml is contraindicated in breastfeeding women. Please consult a doctor if you are breastfeeding.
Driving
Safe if prescribed
Cetrohope 0.25 mg PFS Injection 0.5 ml usually does not affect your ability to drive or operate machinery.
Liver
Caution
If you have any concerns regarding the use of Cetrohope 0.25 mg PFS Injection 0.5 ml in patients with Liver problems, please consult a doctor.
Kidney
Caution
If you have any concerns regarding using Cetrohope 0.25 mg PFS Injection 0.5 ml in patients with kidney problems, please consult a doctor. Avoid using Cetrohope 0.25 mg PFS Injection 0.5 ml if you have severe kidney disease.
Children
Unsafe
Cetrohope 0.25 mg PFS Injection 0.5 ml is not recommended for children.
Heart
Caution
Limited information was available regarding the use of Cetrohope 0.25 mg PFS Injection 0.5 ml in patients with heart problems. Please consult your doctor before receiving Cetrohope 0.25 mg PFS Injection 0.5 ml.
Geriatrics
Caution
Limited information is available regarding the use of Cetrohope 0.25 mg PFS Injection 0.5 ml in elderly patients. If you have any concerns about the usage of Cetrohope 0.25 mg PFS Injection 0.5 ml in geriatrics, please consult your doctor.
Cetrohope 0.25 mg PFS Injection 0.5 ml contains Cetrorelix that works by blocking a natural hormone in the body and inhibits premature ovulation (release of eggs from the ovary too early).
Cetrohope 0.25 mg PFS Injection 0.5 ml may cause ovarian hyper-stimulation syndrome (OHSS) if used along with other medicines that cause stimulation of ovaries to develop more ready-to-be-released eggs. However, if you experience lower stomach pain with nausea or vomiting, please consult a doctor as these might be signs of OHSS.
Cetrohope 0.25 mg PFS Injection 0.5 ml may be used in women undergoing IVF (in-vitro fertilization) treatment to prevent premature release of eggs so that mature eggs can be collected directly from ovaries. However, please consult a doctor before using Cetrohope 0.25 mg PFS Injection 0.5 ml.
You are recommended to consult a doctor before using Cetrohope 0.25 mg PFS Injection 0.5 ml during more than 1 menstrual cycle so that the doctor may check the benefits and risks of using Cetrohope 0.25 mg PFS Injection 0.5 ml.
Cetrohope 0.25 mg PFS Injection 0.5 ml may cause miscarriage, birth defects, or stillbirth. Therefore, avoid Cetrohope 0.25 mg PFS Injection 0.5 ml if you are pregnant and consult a doctor.
You are advised to follow instructions given by your doctor if you are taking Cetrohope 0.25 mg PFS Injection 0.5 ml at home. Inject Cetrohope 0.25 mg PFS Injection 0.5 ml under the belly's skin and select different parts of your belly every day to minimize skin irritation.
Cetrohope 0.25 mg PFS Injection 0.5 ml is an anti-gonadotropin-releasing hormone medicine. It is used for the prevention of premature ovulation in patients undergoing controlled ovarian stimulation.
Cetrohope 0.25 mg PFS Injection 0.5 ml will usually be administered by a doctor. If you are asked to take Cetrohope 0.25 mg PFS Injection 0.5 ml by yourself, follow instructions given by your doctor. The dose of Cetrohope 0.25 mg PFS Injection 0.5 ml will be adjusted by your doctor based on the response.
Possible side effects of Cetrohope 0.25 mg PFS Injection 0.5 ml are itching, redness, or swelling at the site of injection, headache, or nausea. If any of these side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information